Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001641172-25-017832

Options or other derivatives

  • Chief Executive Officer acquired 102,498 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bagai Shaun Chief Executive Officer 2025-07-01 Grant or award · Stock Option +102,498 102,498 D
Loading xslF345X05/ownership.xml…